RT
BMY icon

Rockland Trust’s Bristol-Myers Squibb BMY Stock Holding History

Rockland Trust’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47M Sell
146,933
-30,538
-17% -$1.75M 0.33% 72
2026
Q1 		$10.8M Sell
177,471
-1,307
-0.7% -$76.2K 0.43% 66
2025
Q4 		$9.64M Buy
178,778
+5,703
+3% +$274K 0.38% 67
2025
Q3 		$7.81M Sell
173,075
-10,127
-6% -$473K 0.32% 77
2025
Q2 		$8.48M Buy
183,202
+7,949
+5% +$390K 0.41% 70
2025
Q1 		$10.7M Sell
175,253
-20,035
-10% -$1.17M 0.54% 60
2024
Q4 		$11M Sell
195,288
-3,291
-2% -$184K 0.56% 53
2024
Q3 		$10.3M Buy
198,579
+992
+0.5% +$46.5K 0.51% 61
2024
Q2 		$8.21M Buy
197,587
+24,148
+14% +$1.08M 0.43% 63
2024
Q1 		$9.41M Buy
173,439
+4,142
+2% +$211K 0.5% 58
2023
Q4 		$8.69M Buy
169,297
+34,311
+25% +$1.8M 0.48% 59
2023
Q3 		$7.83M Buy
134,986
+3,052
+2% +$187K 0.47% 59
2023
Q2 		$8.44M Buy
131,934
+8,416
+7% +$564K 0.5% 62
2023
Q1 		$8.56M Buy
123,518
+2,284
+2% +$161K 0.54% 61
2022
Q4 		$8.72M Sell
121,234
-144
-0.1% -$10.9K 0.55% 59
2022
Q3 		$8.63M Sell
121,378
-967
-0.8% -$70.1K 0.62% 56
2022
Q2 		$9.42M Sell
122,345
-11,129
-8% -$848K 0.65% 54
2022
Q1 		$9.75M Buy
133,474
+423
+0.3% +$28.4K 0.62% 52
2021
Q4 		$8.29M Buy
133,051
+11,096
+9% +$651K 0.53% 60
2021
Q3 		$7.22M Buy
121,955
+5,984
+5% +$394K 0.5% 61
2021
Q2 		$7.75M Buy
115,971
+1,178
+1% +$76.8K 0.54% 60
2021
Q1 		$7.25M Buy
114,793
+13,666
+14% +$850K 0.52% 61
2020
Q4 		$6.27M Sell
101,127
-3,168
-3% -$195K 0.49% 60
2020
Q3 		$6.29M Sell
104,295
-546
-0.5% -$32.9K 0.54% 56
2020
Q2 		$6.17M Sell
104,841
-2,585
-2% -$155K 0.55% 58
2020
Q1 		$5.99M Sell
107,426
-2,125
-2% -$130K 0.61% 53
2019
Q4 		$7.03M Sell
109,551
-2,643
-2% -$151K 0.58% 56
2019
Q3 		$5.56M Buy
112,194
+6,033
+6% +$284K 0.51% 61
2019
Q2 		$4.81M Buy
106,161
+2,459
+2% +$115K 0.48% 64
2019
Q1 		$4.95M Buy
103,702
+24,355
+31% +$1.21M 0.52% 63
2018
Q4 		$4.13M Buy
79,347
+7,460
+10% +$401K 0.51% 63
2018
Q3 		$4.46M Buy
71,887
+3,735
+5% +$222K 0.55% 54
2018
Q2 		$3.77M Buy
68,152
+3,547
+5% +$192K 0.49% 61
2018
Q1 		$4.09M Sell
64,605
-940
-1% -$60.5K 0.54% 55
2017
Q4 		$4.02M Buy
65,545
+969
+2% +$60.6K 0.52% 56
2017
Q3 		$4.12M Buy
64,576
+2,149
+3% +$125K 0.62% 48
2017
Q2 		$3.48M Buy
62,427
+12,393
+25% +$674K 0.54% 54
2017
Q1 		$2.72M Sell
50,034
-6,122
-11% -$336K 0.43% 59
2016
Q4 		$3.28M Buy
56,156
+6,370
+13% +$348K 0.53% 56
2016
Q3 		$2.68M Buy
49,786
+14,086
+39% +$905K 0.47% 56
2016
Q2 		$2.63M Buy
35,700
+2,562
+8% +$181K 0.45% 56
2016
Q1 		$2.12M Buy
33,138
+9,630
+41% +$607K 0.38% 61
2015
Q4 		$1.62M Sell
23,508
-1,320
-5% -$87.2K 0.28% 66
2015
Q3 		$1.47M Buy
24,828
+450
+2% +$28.5K 0.29% 64
2015
Q2 		$1.62M Sell
24,378
-240
-1% -$15.8K 0.32% 59
2015
Q1 		$1.59M Buy
24,618
+3,194
+15% +$200K 0.34% 59
2014
Q4 		$1.26M Buy
21,424
+418
+2% +$23.6K 0.26% 63
2014
Q3 		$1.07M Buy
21,006
+2,875
+16% +$144K 0.24% 60
2014
Q2 		$880K Sell
18,131
-9,605
-35% -$473K 0.2% 64
2014
Q1 		$1.44M Buy
27,736
+748
+3% +$39.8K 0.34% 49
2013
Q4 		$1.43M Buy
26,988
+690
+3% +$35.1K 0.35% 54
2013
Q3 		$1.22M Buy
26,298
+250
+1% +$11K 0.32% 57
2013
Q2 		$1.16M Buy
+26,048
New +$1.13M 0.32% 58

Other funds holding BMY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Rockland Trust's BMY Position: Q2 2026 in Review

Rockland Trust reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $1.75M and leaving 146,933 shares worth $8.47M. The position accounts for 0.33% of the portfolio, ranked #72.

Rockland Trust first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $11M in Q4 2024. 799 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Rockland Trust held 146,933 shares of Bristol-Myers Squibb worth $8.47M as of Q2 2026.
  • Rockland Trust sold 30,538 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.75M.
  • Bristol-Myers Squibb made up 0.33% of Rockland Trust's portfolio in Q2 2026, its #72 holding.
  • Rockland Trust first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Rockland Trust's Bristol-Myers Squibb position peaked at $11M in Q4 2024.
  • 799 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.